Table 3.
Metrics | Whole | Segment1 | Segment2 | Segment3 | Segment4 | Segment5 | Segment6 | Segment7 |
---|---|---|---|---|---|---|---|---|
fALFF | ↓ | - | - | ↓ | ↓ | - | - | ↓ |
fcMRI | ↓ | - | - | - | ↓ | - | - | ↓ |
↓ denotes significant reduction of thalamic fALFF or thalamo-thalamo fcMRI in MTBI patients compared to controls.
– denotes no significant difference of thalamic fALFF or thalamo-thalamo fcMRI between MTBI patients and controls.